{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:45Z","timestamp":1792788465679,"version":"4.5.0"},"reference-count":45,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"MEXT | Japan Society for the Promotion of Science","award":["21K09610"],"award-info":[{"award-number":["21K09610"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"MEXT | Japan Society for the Promotion of Science","award":["22K09729"],"award-info":[{"award-number":["22K09729"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"MEXT | Japan Society for the Promotion of Science","award":["22K09687"],"award-info":[{"award-number":["22K09687"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"MEXT | Japan Society for the Promotion of Science","award":["23K15866"],"award-info":[{"award-number":["23K15866"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Histochem Cytochem."],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Salivary gland cancer is a rare heterogeneous group of neoplasms with complex histopathologic patterns, including carcinoma with squamous differentiation, for which surgery is the standard treatment. However, further research is essential for developing new therapies. Head and neck squamous cell carcinoma is positive for p63 and negative for the bicellular tight junction protein cingulin (CGN). p63 plays a key role in cancer progression such as cell proliferation, migration, apoptosis, and squamous differentiation. To understand the roles of p63 in salivary duct adenocarcinoma, we investigated the malignancy by using overexpression of deltaNp63 in p63-negative salivary duct adenocarcinoma cells PGC2E derived from parotid gland duct adenocarcinoma. By transfection with deltaNp63, the PGC2E cells exhibited increased nuclear p63 expression and reduced CGN levels at the membrane. Overexpression of deltaNp63 disrupted epithelial polarity and epithelial permeability barriers, promoted cell proliferation and migration, and enhanced cellular metabolism. Treatment with inhibitors of histone deacetylase and nuclear factor kappa B, and antibodies to tumor necrosis factor-\u03b1 and tricellular tight junction protein lipolysis-stimulated lipoprotein receptor induced apoptosis in PGC2E cells. However, overexpression of deltaNp63 prevented the induced apoptosis. These findings suggest that p63 contributes to cancer malignancy and the complex phenotype, and it may be possible to develop a novel treatment via p63:<\/jats:p>","DOI":"10.1369\/00221554261435677","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:31:42Z","timestamp":1779183102000},"page":"385-404","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells"],"prefix":"10.1369","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3194-9499","authenticated-orcid":false,"given":"Masahiko","family":"Oyanagi","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"},{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-3864","authenticated-orcid":false,"given":"Takumi","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Kakiuchi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshi","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"},{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kizuku","family":"Ohwada","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"},{"name":"Department of Otolaryngology-Head and Neck Surgery, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kakuki","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Obata","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurose","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuto","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"},{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ohsaki","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cell Science, Institute of Cancer Research, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"2","key":"e_1_3_2_2_2","article-title":"Salivary duct carcinoma","volume":"26","author":"D'heygere E","year":"2018","unstructured":"D'heygere E, Meulemans J, Vander Poorten V. Salivary duct carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2018;26(2):142\u201351.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"2","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","DOI":"10.1101\/gad.1165104","article-title":"p63 is the molecular switch for initiation of an epithelial stratification program","volume":"18","author":"Koster MI","year":"2004","unstructured":"Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004;18(2):126\u201331.","journal-title":"Genes Dev"},{"key":"e_1_3_2_4_2","article-title":"The dual role of p63 in cancer","volume":"13","author":"Xu Y","year":"2023","unstructured":"Xu Y, Yang X, Xiong Q, Han J, Zhu Q. The dual role of p63 in cancer. Front Oncol. 2023;13:1116061.","journal-title":"Front Oncol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00260-5"},{"issue":"1","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2005.12.013","article-title":"p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis","volume":"9","author":"Rocco JW","year":"2006","unstructured":"Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell. 2006;9(1):45\u201356.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.701986","article-title":"p63 and p53: collaborative partners or dueling rivals?","volume":"9","author":"Woodstock DL","year":"2021","unstructured":"Woodstock DL, Sammons MA, Fischer M. p63 and p53: collaborative partners or dueling rivals? Front Cell Dev Biol. 2021;9:701986.","journal-title":"Front Cell Dev Biol"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112767"},{"issue":"1","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1038\/s41598-024-57895-1","article-title":"Complex and variable regulation of \u0394Np63 and TAp63 by TGF\u03b2 has implications for the dynamics of squamous cell epithelial to mesenchymal transition","volume":"14","author":"Pokorn\u00e1 Z","year":"2024","unstructured":"Pokorn\u00e1 Z, Tylichov\u00e1 Z, Vojtesek B, Coates PJ. Complex and variable regulation of \u0394Np63 and TAp63 by TGF\u03b2 has implications for the dynamics of squamous cell epithelial to mesenchymal transition. Sci Rep. 2024;14(1):7304.","journal-title":"Sci Rep"},{"issue":"2","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2021.07.010","article-title":"Diagnostic utility of p63\/p40 in the histologic differentiation of salivary gland tumors: a systematic review","volume":"133","author":"Sivakumar N","year":"2022","unstructured":"Sivakumar N, Narwal A, Pandiar D, Devi A, Anand R, Bansal D, Kamboj M. Diagnostic utility of p63\/p40 in the histologic differentiation of salivary gland tumors: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;133(2):189\u201398.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6046","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky N","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cort\u00e9s ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escare\u00f1o C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157\u201360.","journal-title":"Science"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.072058","article-title":"LSR defines cell corners for tricellular tight junction formation in epithelial cells","volume":"124","author":"Masuda S","year":"2011","unstructured":"Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, Furuse M. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci. 2011;124(Pt 4):548\u20135.","journal-title":"J Cell Sci"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2012.06486.x","article-title":"Lipolysis-stimulated lipoprotein receptor: a novel membrane protein of tricellular tight junctions","volume":"1257","author":"Furuse M","year":"2012","unstructured":"Furuse M, Oda Y, Higashi T, Iwamoto N, Masuda S. Lipolysis-stimulated lipoprotein receptor: a novel membrane protein of tricellular tight junctions. Ann N Y Acad Sci. 2012;1257:54\u20138.","journal-title":"Ann N Y Acad Sci"},{"issue":"14","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.3390\/ijms20143555","article-title":"Role of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor (LSR) in cancer cells","volume":"20","author":"Kohno T","year":"2019","unstructured":"Kohno T, Konno T, Kojima T. Role of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor (LSR) in cancer cells. Int J Mol Sci. 2019;20(14):3555.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246341"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.147.7.1569","article-title":"Cingulin contains globular and coiled- coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin","volume":"147","author":"Cordenonsi M","year":"1999","unstructured":"Cordenonsi M, D\u2019Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S. Cingulin contains globular and coiled- coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol. 1999;147:1569\u201382.","journal-title":"J Cell Biol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201304194","article-title":"The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK","volume":"203","author":"Yano T","year":"2013","unstructured":"Yano T, Matsui T, Tamura A, Uji M, Tsukita S. The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK. J Cell Biol. 2013;203:605\u201314.","journal-title":"J Cell Biol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1369\/0022155419886263"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112584"},{"issue":"1","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41368-025-00349-9","article-title":"Loss of tricellular tight junction tricellulin leads to hyposalivation in Sjogren\u2019s syndrome","volume":"17","author":"Mao X","year":"2025","unstructured":"Mao X, Li H, Min S, Su J, Wei P, Zhang Y, He Q, Wu L, Yu G, Cong X. Loss of tricellular tight junction tricellulin leads to hyposalivation in Sjogren\u2019s syndrome. Int J Oral Sci. 2025;17(1):22.","journal-title":"Int J Oral Sci"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239138"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers7010070"},{"issue":"4","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami M","year":"2019","unstructured":"Murakami M, Kamimura D, Hirano T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity. 2019;50(4):812\u201331.","journal-title":"Immunity"},{"issue":"9","key":"e_1_3_2_24_2","article-title":"Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K\/Akt, and NF-\u03baB pathways","volume":"47","author":"Wei L","year":"2018","unstructured":"Wei L, Xiong H, Li W, Li B, Cheng Y. Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K\/Akt, and NF-\u03baB pathways. J Oral Pathol Med. 2018;47(9):847\u201355.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/joe.0.1800055","article-title":"Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands","volume":"180","author":"V\u00e4limaa H","year":"2004","unstructured":"V\u00e4limaa H, Savolainen S, Soukka T, Silvoniemi P, M\u00e4kel\u00e4 S, Kujari H, Gustafsson JA, Laine M. Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 2004;180(1):55\u201362.","journal-title":"J Endocrinol"},{"issue":"9","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1920478117","article-title":"Ventral prostate and mammary gland phenotype in mice with complete deletion of the ER\u03b2 gene","volume":"117","author":"Warner M","year":"2020","unstructured":"Warner M, Wu WF, Montanholi L, Nalvarte I, Antonson P, Gustafsson JA. Ventral prostate and mammary gland phenotype in mice with complete deletion of the ER\u03b2 gene. Proc Natl Acad Sci U S A. 2020;117(9):4902\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2303","article-title":"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal","volume":"13","author":"Zhao B","year":"2011","unstructured":"Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13(8):877\u20133.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10985549.2023.2292037","article-title":"A non-canonical Hippo pathway represses the expression of \u0394Np63","volume":"44","author":"Low-Calle AM","year":"2024","unstructured":"Low-Calle AM, Ghoneima H, Ortega N, Cuibus AM, Katz C, Prives C, Prywes R. A non-canonical Hippo pathway represses the expression of \u0394Np63. Mol Cell Biol. 2024;44(1):27\u201342.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10637-005-5854-9","article-title":"Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines","volume":"23","author":"Sonnemann J","year":"2005","unstructured":"Sonnemann J, G\u00e4nge J, Kumar KS, M\u00fcller C, Bader P, Beck JF. Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. Invest New Drugs. 2005;23(2):99\u2013109.","journal-title":"Invest New Drugs"},{"issue":"5","key":"e_1_3_2_30_2","article-title":"HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells","volume":"69","author":"Shin MW","year":"2023","unstructured":"Shin MW, Seo SY, Kim SL, Kim SW. HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells. Cell Mol Biol (Noisy-le-grand). 2023;69(5):12\u20138.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"2","key":"e_1_3_2_31_2","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah RR.","year":"2019","unstructured":"Shah RR. Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology. Drug Saf. 2019;42(2):235\u201345.","journal-title":"Drug Saf"},{"issue":"6","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","DOI":"10.1007\/s13318-021-00722-z","article-title":"Population pharmacokinetic analysis from first-in-human data for HDAC inhibitor, REC-2282 (AR-42), in patients with solid tumors and hematologic malignancies: A case study for evaluating flat vs. body size normalized dosing","volume":"46","author":"Liva S","year":"2021","unstructured":"Liva S, Chen M, Mortazavi A, Walker A, Wang J, Dittmar K, Hofmeister C, Coss CC, Phelps MA. Population pharmacokinetic analysis from first-in-human data for HDAC inhibitor, REC-2282 (AR-42), in patients with solid tumors and hematologic malignancies: A case study for evaluating flat vs. body size normalized dosing. Eur J Drug Metab Pharmacokinet. 2021;46(6):807\u201316.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"11","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","DOI":"10.1111\/cas.12271","article-title":"Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck","volume":"104","author":"Chikamatsu K","year":"2013","unstructured":"Chikamatsu K, Ishii H, Murata T, Sakakura K, Shino M, Toyoda M, Takahashi K, Masuyama K. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. Cancer Sci. 2013;104(11):1468\u201375.","journal-title":"Cancer Sci"},{"issue":"22","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-09-0547","article-title":"JNJ- 26481585, a novel \u201csecond-generation\u201d oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity","volume":"15","author":"Arts J","year":"2009","unstructured":"Arts J, King P, Mari\u00ebn A, Floren W, Beli\u00ebn A, Janssen L, Pilatte I, Roux B, Decrane L, Gilissen R, Hickson I, Vreys V, Cox E, Bol K, Talloen W, Goris I, Andries L, Du Jardin M, Janicot M, Page M, van Emelen K, Angibaud P. JNJ- 26481585, a novel \u201csecond-generation\u201d oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Clin Cancer Res. 2009;15(22):6841\u201351.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"e_1_3_2_35_2","article-title":"Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation","volume":"32","author":"Bao L","year":"2016","unstructured":"Bao L, Diao H, Dong N, Su X, Wang B, Mo Q, Yu H, Wang X, Chen C. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation. Cell Biol Toxicol. 2016;32(6):469\u201382.","journal-title":"Cell Biol Toxicol"},{"issue":"13","key":"e_1_3_2_36_2","article-title":"The HDAC inhibitor quisinostat (JNJ-26481585) supresses hepatocellular carcinoma alone and synergistically in combination with sorafenib by G0\/G1 phase arrest and apoptosis induction","volume":"14","author":"He B","year":"2018","unstructured":"He B, Dai L, Zhang X, Chen D, Wu J, Feng X, Zhang Y, Xie H, Zhou L, Wu J, Zheng S. The HDAC inhibitor quisinostat (JNJ-26481585) supresses hepatocellular carcinoma alone and synergistically in combination with sorafenib by G0\/G1 phase arrest and apoptosis induction. Int J Biol Sci. 2018;14(13):1845\u201358.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2022.2106113","article-title":"LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer","volume":"11","author":"Saito K","year":"2023","unstructured":"Saito K, Konno T, Kohno T, Shimada H, Matsuura M, Okada T, Kura A, Ishii D, Kondoh M, Saito T, Kojima T. LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer. Tissue Barriers. 2023;11(3):2106113.","journal-title":"Tissue Barriers"},{"key":"e_1_3_2_38_2","article-title":"Treatment with TNF\u03b1 and lipolysis-stimulated lipoprotein receptor (LSR) antibody in the presence of HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma","volume":"2024","author":"Nishida S","unstructured":"Nishida S, Konno T, Kohno T, Ohyanagi M, Nakano M, Ohwada K, Obata K, Kakuki T, Kakiuchi A, Kurose M, Takano K, Kojima T. Treatment with TNF\u03b1 and lipolysis-stimulated lipoprotein receptor (LSR) antibody in the presence of HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma. Tissue Barriers. 2024:2437215.","journal-title":"Tissue Barriers"},{"issue":"12","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita S","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7(12):1063\u20136.","journal-title":"Gene Ther"},{"key":"e_1_3_2_40_2","article-title":"Cingulin family: structure, function and clinical significance","volume":"341","author":"Su Y","year":"2024","unstructured":"Su Y, Long Y, Xie K. Cingulin family: structure, function and clinical significance. Life Sci. 2024;341:122504.","journal-title":"Life Sci"},{"issue":"1","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-024-02987-z","article-title":"Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition","volume":"43","author":"Huang YT","year":"2024","unstructured":"Huang YT, Hsu YT, Wu PY, Yeh YM, Lin PC, Hsu KF, Shen MR. Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2024;43(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"2361976","DOI":"10.1080\/21688370.2024.2361976","article-title":"The roles of tight junction protein cingulin in human endometrioid endometrial cancer","volume":"13","author":"Kura A","year":"2025","unstructured":"Kura A, Saito K, Konno T, Kohno T, Shimada H, Okada T, Nishida S, Ishii D, Matsuura M, Saito T, Kojima T. The roles of tight junction protein cingulin in human endometrioid endometrial cancer. Tissue Barriers. 2025;13(2):2361976.","journal-title":"Tissue Barriers"},{"issue":"5","key":"e_1_3_2_43_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI79573","article-title":"Estrogen regulates Hippo signaling via GPER in breast cancer","volume":"125","author":"Zhou X","unstructured":"Zhou X, Wang S, Wang Z, Feng X, Liu P, Lv XB, Li F, Yu FX, Sun Y, Yuan H, Zhu H, Xiong Y, Lei QY, Guan KL. Estrogen regulates Hippo signaling via GPER in breast cancer. J Clin Invest. 201;125(5):2123\u201335.","journal-title":"J Clin Invest"},{"issue":"37","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1508871112","article-title":"p63 supports aerobic respiration through hexokinase II","volume":"112","author":"Viticchi\u00e8 G","year":"2015","unstructured":"Viticchi\u00e8 G, Agostini M, Lena AM, Mancini M, Zhou H, Zolla L, Dinsdale D, Saintigny G, Melino G, Candi E. p63 supports aerobic respiration through hexokinase II.Proc Natl Acad Sci U S A. 2015;112(37):11577\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061913"},{"issue":"8","key":"e_1_3_2_46_2","article-title":"Paraneoplastic neurological syndromes associated with parotid cancer expressing the Zic4 antibody: a case report","volume":"17","author":"Oyanagi M","year":"2025","unstructured":"Oyanagi M, Kakiuchi A, Yamamoto K, Kurose M, Takano K. Paraneoplastic neurological syndromes associated with parotid cancer expressing the Zic4 antibody: a case report. Cureus. 2025;17(8):e90210.","journal-title":"Cureus"}],"container-title":["Journal of Histochemistry &amp; Cytochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1369\/00221554261435677","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1369\/00221554261435677","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1369\/00221554261435677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:04:50Z","timestamp":1791518690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1369\/00221554261435677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1369\/00221554261435677"],"URL":"https:\/\/doi.org\/10.1369\/00221554261435677","relation":{},"ISSN":["0022-1554","1551-5044"],"issn-type":[{"value":"0022-1554","type":"print"},{"value":"1551-5044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}